News

Geopacific has unlocked a new phase of district-scale exploration with 14 new porphyry target environments at its Woodlark ...
Neuren Pharmaceuticals says fewer US Rett syndrome patients are discontinuing its breakthrough drug Daybue. ... Read More The ...